Exhibit 32.1
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Codiak BioSciences, Inc. (the “Company”) for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:
|
|
|
|
Date: March 10, 2022 |
| By: | /s/ DOUGLAS E. WILLIAMS
|
|
|
| Douglas E. Williams, Ph.D. |
|
|
| Chief Executive Officer and President |
|
|
| (Principal Executive Officer) |
|
|
|
|
Date: March 10, 2022 |
| By: | /s/ Linda C. Bain
|
|
|
| Linda C. Bain |
|
|
| Chief Financial Officer |
|
|
| (Principal Financial and Accounting Officer) |